Sarclisa Escena is a newer formulation of Sarclisa. Both are approved by the FDA for treating patients with newly diagnosed multiple myeloma (NDMM) or with relapsed/refractory multiple myeloma (RRMM). Both formulations have the same active ingredient and are very effective in treating myeloma.

*updated 9/28/2026